Jan. 7 Financial Quick Takes: Deep Genomics raises $40M; plus Arcutis, Kintor file for IPOs, TwinStrand and RootPath

Future Ventures leads Deep Genomics’ $40M series B
Looking to submit INDs for two programs this year, Deep Genomics Inc. raised $40 million in a series B round led by Future Ventures, with participation from Amplitude Ventures, Khosla Ventures, Magnetic Ventures and True Ventures. The company uses its AI Workbench to discover and develop therapies for rare genetic diseases. It expects to Phase I/II data in 2021 for lead candidate DG12P1 to treat Wilson disease (see “Letting AI Take the Wheel”).

Arcutis files for IPO...